Peptides and Obesity: Evaluating Intranasal Administration of Peptides for Therapeutic Potential
Obesity Reviews · 16.11.2026
DOI: 10.1111/obr.70259 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Obesity Reviews, online erschienen am 16.11.2026. Verfasst von Karthi Duraisamy und 11 weiteren Autor:innen. Beteiligte Einrichtung: Inserm U1239 NorDiC, Université de Rouen Normandie, Rouen, France. Die Arbeit nennt 237 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: European Union's Horizon 2020, Laboratory of Neurophysiology, Cellular Physiopathology and Biomolecules Valorisation, France-Tunisia CMCU-Campus France/PHC Utique.
Abstract (Originalsprache)
Obesity is a complex global health issue characterized by an imbalance in energy homeostasis and associated with significant health risks, including cardiovascular diseases, diabetes, and cancer. While various therapeutic approaches exist, peptide‐based treatments have emerged as promising candidates due to their specificity and reduced side effects. Because many of the mechanisms are centrally regulated in the brain, effective intervention requires peptides with good brain penetration or alternative delivery strategies. In this context, this review explores the potential of intranasal delivery of therapeutic peptide candidates for obesity management, highlighting its advantages in bypassing the blood–brain barrier, targeting central pathways regulating appetite and energy expenditure, and minimizing systemic exposure, while also considering the translational limitations of this delivery route. The review analyses established and emerging peptides, including leptin, GLP‐1 analogs, and oxytocin, focusing on their central mechanisms of action, specifically their ability to target the brain. It highlights how these peptides regulate energy homeostasis, appetite, and metabolism through direct activation of neural circuits in the hypothalamus, brainstem, and other key regions involved in obesity management. Furthermore, it evaluates the prospects of intranasal peptide therapeutics as an innovative strategy in obesity treatment, addressing both the opportunities and limitations in the context of clinical and preclinical evidence. Continued research and technological advancements are essential to optimize peptide formulations and delivery systems, ensuring efficacy, safety, and patient compliance in combating the obesity epidemic.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Inserm U1239 NorDiC, Université de Rouen Normandie, Rouen, France.
- Laboratoire de Neurophysiologie et Physiopathologie Cellulaire et Valorisation des Biomolécules, Université de Tunis El Manar, Tunis, Tunisia.
- Inserm US51 HeRacLeS, Primacen, Université de Rouen Normandie, Rouen, France.
ORCID-Profile: Karthi Duraisamy, Omayma Dlimi, Amine Bourzam, Benjamin Lefranc, Marie-Anne Le Solliec, Jean A Boutin, Olfa Masmoudi, Sergueï O Fetissov, Gaëtan Prévost, Jérôme Leprince
Förderung
- European Union's Horizon 2020
- Laboratory of Neurophysiology, Cellular Physiopathology and Biomolecules Valorisation
- France-Tunisia CMCU-Campus France/PHC Utique
- Horizon Europe Marie Skłodowska-Curie Actions PsyCoMed
Zitieren
APA
Duraisamy, K., Dlimi, O., Bourzam, A., Lefranc, B., Le Solliec, M. A., Picot, M., Chartrel, N., Boutin, J. A., Masmoudi, O., Fetissov, S. O., Prévost, G., & Leprince, J. (2026). Peptides and Obesity: Evaluating Intranasal Administration of Peptides for Therapeutic Potential. Obesity Reviews. https://doi.org/10.1111/obr.70259
Vancouver
Duraisamy K, Dlimi O, Bourzam A, Lefranc B, Le Solliec MA, Picot M, et al. Peptides and Obesity: Evaluating Intranasal Administration of Peptides for Therapeutic Potential. Obesity Reviews. 2026. doi:10.1111/obr.70259
BibTeX
@article{Duraisamy2026,
author = {Duraisamy, Karthi and Dlimi, Omayma and Bourzam, Amine and Lefranc, Benjamin and Le Solliec, Marie-Anne and Picot, Marie and Chartrel, Nicolas and Boutin, Jean A and Masmoudi, Olfa and Fetissov, Sergueï O and Prévost, Gaëtan and Leprince, Jérôme},
title = {Peptides and Obesity: Evaluating Intranasal Administration of Peptides for Therapeutic Potential},
journal = {Obesity Reviews},
year = {2026},
doi = {10.1111/obr.70259}
}
EUVIMED